Kırşehir Ahi Evran University
Kırşehir, Turkey (Türkiye)
NCT Number: NCT07107763
Pes Planus (PP) is a foot deformity characterized by a lower-than-normal medial longitudinal arch. Individuals diagnosed with PP experience various challenges in daily life. Among these challenges are limitations in balance and movement skills. To reduce the effects of PP, several treatment approaches are preferred. These interventions are generally categorized into surgical and conventional treatments. Among conservative approaches, the short foot exercise is one of the most fundamental and commonly used methods. This exercise aims to strengthen the intrinsic muscles of the foot to support the arch. In addition to the short foot exercise, other exercises such as towel scrunching and toe spreading are also used in the management of PP. However, when looking at the treatment options for PP, studies examining the use and effects of joint mobilization are limited. The present study aims to investigate the effects of subtalar joint mobilization, short foot exercises, and the combined application of these interventions in individuals with PP. This approach is based on findings that subtalar joint mobilization has positive effects on balance in individuals with balance impairments.
Looking for future studies?
Notify Me18 year–30 year
All sexes
Interventional
Not applicable
Kırşehir, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The short foot exercise group will receive stretching exercises and short foot exercises, administered three sessions per week for a duration of six weeks.
The mobilization group will undergo a program consisting of 3 sessions per week for a duration of 6 weeks. The sessions will begin with stretching exercises, followed by subtalar joint mobilization.
The combined intervention used in this group will include both of the approaches applied in the other two groups.
Time frame: From enrollment to the end of treatment at 6 weeks
Time frame: From enrollment to the end of treatment at 6 weeks
Time frame: From enrollment to the end of treatment at 6 weeks
Time frame: From enrollment to the end of treatment at 6 weeks
Kirsehir Ahi Evran Universitesi
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07632924
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Malatya, Turkey (Türkiye)
View Trial DetailsNCT07326020
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07426887
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Sialkot, Punjab Province, Pakistan
View Trial DetailsNCT07123753
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Gaziantep, Nizip, Turkey (Türkiye)
View Trial Details